A randomized phase II trial of adjuvant Pembrolizumab versus observation following curative resection forstage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer ResearchConsortium BTCRC-LUN18-153

Project: Research project

Project Details

Description

A randomized phase II trial of adjuvant Pembrolizumab versus observation following curative resection for stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153
StatusActive
Effective start/end date6/29/20 → 6/30/26

Funding

  • BIG TEN CANCER RESEARCH CONSORTIUM

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint